Reaction

Wrong Patient Received Product reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,823 reports · 68 co-occurring drugs

As of the last recalculation, Wrong Patient Received Product appears in 2,823 FAERS reports alongside 68 co-occurring drug terms. The strongest observed disproportionality signal is OXAZEPAM (PRR 44.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Oxazepam	123	44.1	44.3
Valproate Sodium	116	43.1	43.3
Dutasteride	42	38.6	38.8
Daptomycin	33	26.7	26.8
Desloratadine	32	22.2	22.3
Insulin Lispro	341	20.6	20.6
Promethazine Hydrochloride	41	16.5	16.5
Clozapine	232	14.8	14.8
Risperidone	236	14.2	14.2
Valproic Acid	50	11.9	11.9
Clobazam	36	11.0	11.0
Levetiracetam In Sodium Chloride	110	10.9	10.9
Levetiracetam Oral	110	10.9	10.9
Levetiracetam Injection	110	10.8	10.9
Irbesartan	62	10.4	10.5
Bisoprolol Fumarate	177	10.2	10.2
Divalproex Sodium	60	9.7	9.7
Lamotirigine	91	9.6	9.7
Lamotrigine Extended-Release	91	9.6	9.7
Lamotrigine Chewable Dispersible	91	9.6	9.7
Dulaglutide	110	9.5	9.5
Mirtazapine	113	9.4	9.4
Nebivolol	19	8.8	8.9
Lacosamide	44	8.8	8.8
Lithium	29	8.6	8.6
Lithium Bromatum	29	8.6	8.6
Phenytoin	24	8.5	8.6
Instalax Polyethylene Glycol 3350	14	8.4	8.4
Lamotrigine	142	8.3	8.3
Polyethylene Glycol 400	14	8.2	8.2
Tramadol Hydrochloride	41	8.1	8.1
Levetiracetam	140	8.1	8.1
Olanzapine	110	7.8	7.8
Oxcarbazepine	33	7.6	7.6
Aripiprazole Oral	41	7.4	7.4
Aripiprazole Orally Disintegrating	41	7.4	7.4
Carbamazepine	65	7.3	7.3
Phenobarbital	14	7.2	7.2
Atropine	8	7.1	7.1
Insulin Human	38	7.1	7.1
Quetiapine Fumarate	28	7.1	7.1
Insulin Degludec	22	7.0	7.0
Brivaracetam	8	6.6	6.6
Tirzepatide	129	6.1	6.1
Quetiapine	149	6.0	6.0
Tizanidine	19	5.9	5.9
Zonisamide	11	5.5	5.5
Tamsulosin Hydrochloride	15	5.4	5.4
Insulin Glargine	172	5.4	5.4
Isosorbide Mononitrate	15	5.4	5.4
Lansoprazole	123	5.3	5.3
Haloperidol	17	5.2	5.2
Haloperidol Lactate	17	5.1	5.1
Dapagliflozin	21	5.0	5.0
Metformin Hydrochloride Tablets	38	4.9	4.9
Metformin Hydrochloride Extended-Release Tablets	38	4.9	4.9
Metformin Hydrochloride Tablet	38	4.9	4.9
Metformin Hydrochloride	38	4.8	4.8
Nebivolol Hydrochloride	20	4.4	4.4
Linezolid	17	4.2	4.2
Fesoterodine Fumarate	6	4.1	4.1
Galcanezumab-Gnlm	17	4.0	4.0
Lutetium Lu 177 Vipivotide Tetraxetan	5	2.8	2.8
Orlistat	9	2.6	2.6
Vigabatrin	5	2.5	2.5
Esketamine Hydrochloride	6	2.5	2.5
Lifitegrast	4	1.8	1.8
Paliperidone Palmitate	7	1.6	1.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.